Home > Boards > US OTC > Biotechs > Vivos Inc. (RDGL)

The publication of the animal clinic results is

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
bdvest Member Profile
 
Followed By 8
Posts 751
Boards Moderated 0
Alias Born 10/11/18
160x600 placeholder
Amended Quarterly Report (10-q/a) Edgar (US Regulatory) - 11/14/2019 3:21:50 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/12/2019 11:03:10 AM
Amended Registration a Offering Under the Securities Act of 1933 (1-a/a) Edgar (US Regulatory) - 10/8/2019 5:25:19 PM
Amended Registration a Offering Under the Securities Act of 1933 (1-a/a) Edgar (US Regulatory) - 9/9/2019 11:58:14 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/13/2019 3:46:20 PM
Registration a Offering Under the Securities Act of 1933 (1-a) Edgar (US Regulatory) - 7/29/2019 11:45:35 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/2/2019 1:27:29 PM
Amended Quarterly Report (10-q/a) Edgar (US Regulatory) - 6/24/2019 1:20:58 PM
Information Statement (definitive, Revised) (defr14c) Edgar (US Regulatory) - 5/22/2019 5:03:56 PM
Information Statement - All Other (definitive) (def 14c) Edgar (US Regulatory) - 5/16/2019 1:48:24 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/13/2019 4:17:48 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/6/2019 6:05:49 PM
Proxy Statement - Other Information (preliminary) (pre 14c) Edgar (US Regulatory) - 4/29/2019 6:16:09 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/2/2019 5:14:00 PM
Annual Report (10-k) Edgar (US Regulatory) - 3/25/2019 1:29:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/31/2019 5:22:33 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 12/12/2018 2:45:26 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/11/2018 6:12:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/6/2018 6:10:34 AM
bdvest   Sunday, 10/20/19 01:53:30 PM
Re: bdvest post# 125178
Post # of 125628 
The publication of the animal clinic results is much worthy of a PR.
It is the milestone of isopet clinical indications (human version will be radiogel), It is the great approval of the effectiveness of isopet and soon radiogel to human. It would be not wise if there were no PR of it. Dr. Korenko needs to build a better investor relationship while doing all the diligent CEO work there.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist